Autres langues GSK plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:08 30/05/2024			Varia. 5j.	Varia. 1 janv.
1 730 ^GBX	-0,94 %		-2,70 %	+19,29 %

30/05	GSK PLC : Goldman Sachs moins optimiste	ZM
30/05	GSK PLC : Goldman Sachs confirme sa recommandation neutre	ZM

Jefferies and UBS cut Anglo American	30/05
Dr Martens cuts payout as profit plummets	30/05
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	30/05
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	29/05
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	29/05
CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate	28/05
EEUU y los países europeos estudian vacunar a los trabajadores expuestos a la gripe aviar	27/05
Usa e Paesi europei considerano vaccinazione per lavoratori esposti a influenza aviaria	27/05
US, European nations consider vaccinating workers exposed to bird flu	27/05
British Stocks Extend Losing Streak Amid Retail Sales Slump	24/05
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases - Form 6-K	24/05
Rate outlook weighs on equities	24/05
GSK : obtient gain de cause dans une affaire liée au Zantac	24/05
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	24/05
GSK : va présenter ses avancées en oncologie lors de l'ASCO	24/05
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases \| GSK	24/05
FTSE 100 falls; retail sales plunge in April	24/05
GSK celebrates Illinois jury verdict in Valadez case	24/05
GSK to Continue Vigorous Defense of Zantac Cancer Claims After Recent US Victory	24/05
UK retail sales fall amid wet April; Co-Op Bank deal	24/05

Aucun résultat pour cette recherche

GSK plc : Reprend des couleurs

Le 03 mai 2024 à 11:03

GSK PLC : Début encourageant pour 2024 ; révision à la hausse des prévisions